617 related articles for article (PubMed ID: 24253566)
21. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196.
Perelle S; Gibert M; Bourlioux P; Corthier G; Popoff MR
Infect Immun; 1997 Apr; 65(4):1402-7. PubMed ID: 9119480
[TBL] [Abstract][Full Text] [Related]
22. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
23. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile.
Stubbs S; Rupnik M; Gibert M; Brazier J; Duerden B; Popoff M
FEMS Microbiol Lett; 2000 May; 186(2):307-12. PubMed ID: 10802189
[TBL] [Abstract][Full Text] [Related]
24. (1)H(N), (13)C, and (15)N resonance assignments of the CDTb-interacting domain (CDTaBID) from the Clostridium difficile binary toxin catalytic component (CDTa, residues 1-221).
Roth BM; Varney KM; Rustandi RR; Weber DJ
Biomol NMR Assign; 2016 Oct; 10(2):335-9. PubMed ID: 27351891
[TBL] [Abstract][Full Text] [Related]
25. Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDT.
Unger M; Eichhoff AM; Schumacher L; Strysio M; Menzel S; Schwan C; Alzogaray V; Zylberman V; Seman M; Brandner J; Rohde H; Zhu K; Haag F; Mittrücker HW; Goldbaum F; Aktories K; Koch-Nolte F
Sci Rep; 2015 Jan; 5():7850. PubMed ID: 25597743
[TBL] [Abstract][Full Text] [Related]
26. A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain.
Wehrhahn MC; Keighley C; Kurtovic J; Knight DR; Hong S; Hutton ML; Lyras D; Wang Q; Leong R; Borody T; Edye M; Riley TV
Anaerobe; 2019 Feb; 55():117-123. PubMed ID: 30500477
[TBL] [Abstract][Full Text] [Related]
27. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
[TBL] [Abstract][Full Text] [Related]
28. Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT.
Roeder M; Nestorovich EM; Karginov VA; Schwan C; Aktories K; Barth H
Toxins (Basel); 2014 Jul; 6(7):2097-114. PubMed ID: 25029374
[TBL] [Abstract][Full Text] [Related]
29. Functional significance of active site residues in the enzymatic component of the
Davies AH; McGlashan J; Posner MG; Roberts AK; Shone CC; Acharya KR
Biochem Biophys Rep; 2016 Dec; 8():55-61. PubMed ID: 28955942
[No Abstract] [Full Text] [Related]
30. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
31. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain.
Kuehne SA; Collery MM; Kelly ML; Cartman ST; Cockayne A; Minton NP
J Infect Dis; 2014 Jan; 209(1):83-6. PubMed ID: 23935202
[TBL] [Abstract][Full Text] [Related]
32. Development of Clostridium difficile R20291ΔPaLoc model strains and in vitro methodologies reveals CdtR is required for the production of CDT to cytotoxic levels.
Bilverstone TW; Kinsmore NL; Minton NP; Kuehne SA
Anaerobe; 2017 Apr; 44():51-54. PubMed ID: 28108389
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
[TBL] [Abstract][Full Text] [Related]
34. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019.
Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E
Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
Gülke I; Pfeifer G; Liese J; Fritz M; Hofmann F; Aktories K; Barth H
Infect Immun; 2001 Oct; 69(10):6004-11. PubMed ID: 11553537
[TBL] [Abstract][Full Text] [Related]
37. Cyclophilin-facilitated membrane translocation as pharmacological target to prevent intoxication of mammalian cells by binary clostridial actin ADP-ribosylated toxins.
Ernst K; Langer S; Kaiser E; Osseforth C; Michaelis J; Popoff MR; Schwan C; Aktories K; Kahlert V; Malesevic M; Schiene-Fischer C; Barth H
J Mol Biol; 2015 Mar; 427(6 Pt A):1224-38. PubMed ID: 25058685
[TBL] [Abstract][Full Text] [Related]
38. Binary toxin producing Clostridium difficile strains.
Rupnik M; Grabnar M; Geric B
Anaerobe; 2003 Dec; 9(6):289-94. PubMed ID: 16887714
[TBL] [Abstract][Full Text] [Related]
39.
Alam MZ; Madan R
Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922136
[No Abstract] [Full Text] [Related]
40. Structure of the cell-binding component of the
Xu X; Godoy-Ruiz R; Adipietro KA; Peralta C; Ben-Hail D; Varney KM; Cook ME; Roth BM; Wilder PT; Cleveland T; Grishaev A; Neu HM; Michel SLJ; Yu W; Beckett D; Rustandi RR; Lancaster C; Loughney JW; Kristopeit A; Christanti S; Olson JW; MacKerell AD; Georges AD; Pozharski E; Weber DJ
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1049-1058. PubMed ID: 31896582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
